NASDAQ: CRACCrown Reserve Acquisition Corp I Stock
$10.12+0.01 (+0.1%)
Updated Jun 15, 2026
CRAC Price
$10.12
Fair Value Price
N/A
Market Cap
$226.37M
52 Week Low
$9.89
52 Week High
$10.14
P/E
N/A
P/B
-71.62x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.09
Operating Cash Flow
-$262k
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CRAC Overview
Crown Reserve Acquisition Corp. I, an entity established in the Cayman Islands on April 29, 2025, functions as a Special Purpose Acquisition Company (SPAC) – also known as a blank-check firm. Its core objective is to identify and finalize a merger or acquisition within the broader healthcare sector. This includes a strategic focus on sub-segments such as pharmaceutical development, medical technology (med-tech), the manufacturing of medical equipment, and health information technology (healthcare IT).
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CRAC's potential to beat the market
- CRAC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
CRAC
RankedUnranked of 34
RankedUnranked of 34
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.80 | C | |
| $11.26 | C | |
| $12.26 | C |
Be the first to know about important CRAC news, forecast changes, insider trades & much more!
CRAC News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CRAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CRAC's cash and short-term investments ($0.00) cannot cover CRAC's cash burn for the next year (N/A), even if decreasing cash burn (N/A) is accounted for
Interest Coverage Financials
CRAC's short-term liabilities ($3.43M) exceed its short-term assets ($273.57k)
Short-term Liabilities Financials
CRAC's short-term assets ($273.57k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more CRAC due diligence checks available for Premium users.
Valuation
CRAC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-71.62x
Industry
78.39x
CRAC's financial health
Profit margin
Revenue
$0.0
Net Income
-$263.5k
Profit Margin
0%
CRAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$175.2M
Liabilities
$3.4M
Debt to equity
-1.09
CRAC's short-term liabilities ($3.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRAC's short-term assets ($273.57k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CRAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$237.4k
Investing
$0.0
Financing
$237.4k
CRAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CRAC vs Shell Company Stocks
Crown Reserve Acquisition I Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.